Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia

Results of a Multicenter, Controlled, Randomized Clinical Trial Evaluating the Combination of Piperacillin/Tazobactam and Tigecycline in High-Risk Hematologic Patients With Cancer With Febrile Neutropenia

(2014) Giampaolo Bucaneve et al.   JOURNAL OF CLINICAL ONCOLOGY

Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on

(2013) Elio Castagnola et al.   EXPERT OPINION ON EMERGING DRUGS

European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia

(2013) D. Averbuch et al.   HAEMATOLOGICA

Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients

(2013) Małgorzata Mikulska et al.   JOURNAL OF INFECTION

Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance

(2013) Sally C Davies et al.   LANCET

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

(2013) L Silvia Munoz-Price et al.   LANCET INFECTIOUS DISEASES

Antibiotic-resistant Gram-negative Bacteremia in Pediatric Oncology Patients—Risk Factors and Outcomes

(2013) Gabrielle M. Haeusler et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Combination Therapy for Treatment of Infections with Gram-Negative Bacteria

(2012) P. D. Tamma et al.   CLINICAL MICROBIOLOGY REVIEWS

Guideline for the Management of Fever and Neutropenia in Children With Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation

(2012) Thomas Lehrnbecher et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

A survey on hematology-oncology pediatric AIEOP centers: prophylaxis, empirical therapy and nursing prevention procedures of infectious complications

(2011) S. Livadiotti et al.   HAEMATOLOGICA

Use of antibacterial prophylaxis for patients with neutropenia

(2011) M. A. Slavin et al.   INTERNAL MEDICINE JOURNAL

Use of empiric antimicrobial therapy in neutropenic fever

(2011) C. S. Tam et al.   INTERNAL MEDICINE JOURNAL

On the clinical implications of β-lactam–aminoglycoside synergism

(2011) María Espino-Hernández   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical implications of β-lactam–aminoglycoside synergism: systematic review of randomised trials

(2011) Ronit Marcus et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Fluoroquinolone Prophylaxis Against Febrile Neutropenia in Areas With High Fluoroquinolone Resistance—An Asian Perspective

(2010) Esther Shu-Ting Ng et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia

(2010) Emilie Macher et al.   PEDIATRIC BLOOD & CANCER

Diagnosis and Management of Complicated Intra‐abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

(2009) Joseph S. Solomkin et al.   CLINICAL INFECTIOUS DISEASES